BACKGROUND: We investigated for the first time in a national survey whether older people were less likely than younger adults with the same symptom severity to receive treatment for Common Mental Disorders (CMD). METHOD: We analysed data from the 2007 English Adult Psychiatric Morbidity Survey, representative of people living in private homes. 7461 (57%) people approached took part. We used the revised Clinical Interview Schedule to measure CMD symptom severity. RESULTS: Older participants were less likely than younger adults to receive talking therapy and to have seen their GP in the last year about mental health, and more likely to receive benzodiazepines, after adjusting for CMD symptoms. Adults aged 35-74 were the most likely to take antidepressants. There was also preliminary evidence that people from non-white ethnicities were less likely to be taking antidepressants and to have seen their GP in the last year about their mental health. LIMITATIONS: We only recorded current treatment, and it is possible that older adults were less likely to be receiving treatments they had found unhelpful earlier in their lives. We asked people whether they had seen their GP about a mental health problem in the last year, but this question may not have detected those who attended for somatic manifestations of their anxieties. CONCLUSIONS: Older people are less likely to receive evidence-based treatment for CMD. Managers and clinicians should prioritize reducing this inequality.
BACKGROUND: We investigated for the first time in a national survey whether older people were less likely than younger adults with the same symptom severity to receive treatment for Common Mental Disorders (CMD). METHOD: We analysed data from the 2007 English Adult Psychiatric Morbidity Survey, representative of people living in private homes. 7461 (57%) people approached took part. We used the revised Clinical Interview Schedule to measure CMD symptom severity. RESULTS: Older participants were less likely than younger adults to receive talking therapy and to have seen their GP in the last year about mental health, and more likely to receive benzodiazepines, after adjusting for CMD symptoms. Adults aged 35-74 were the most likely to take antidepressants. There was also preliminary evidence that people from non-white ethnicities were less likely to be taking antidepressants and to have seen their GP in the last year about their mental health. LIMITATIONS: We only recorded current treatment, and it is possible that older adults were less likely to be receiving treatments they had found unhelpful earlier in their lives. We asked people whether they had seen their GP about a mental health problem in the last year, but this question may not have detected those who attended for somatic manifestations of their anxieties. CONCLUSIONS: Older people are less likely to receive evidence-based treatment for CMD. Managers and clinicians should prioritize reducing this inequality.
Authors: Marjolein Veerbeek; Richard Oude Voshaar; Marja Depla; Anne Margriet Pot Journal: Int J Methods Psychiatr Res Date: 2013-05-16 Impact factor: 4.035
Authors: Sophie Pettit; Adam Qureshi; William Lee; Alex Stirzaker; Alex Gibson; William Henley; Richard Byng Journal: Br J Gen Pract Date: 2017-06-05 Impact factor: 5.386
Authors: Conal D Twomey; Martin Prince; Alarcos Cieza; David S Baldwin; A Matthew Prina Journal: Int J Environ Res Public Health Date: 2015-04-02 Impact factor: 3.390
Authors: David Perkins; Jeffrey Fuller; Brian J Kelly; Terry J Lewin; Michael Fitzgerald; Clare Coleman; Kerry J Inder; John Allan; Dinesh Arya; Russell Roberts; Richard Buss Journal: BMC Health Serv Res Date: 2013-04-30 Impact factor: 2.655
Authors: Stephanie L Prady; Kate E Pickett; Simon Gilbody; Emily S Petherick; Dan Mason; Trevor A Sheldon; John Wright Journal: BMC Psychiatry Date: 2016-04-12 Impact factor: 3.630
Authors: Stephanie L Prady; Kate E Pickett; Emily S Petherick; Simon Gilbody; Tim Croudace; Dan Mason; Trevor A Sheldon; John Wright Journal: Br J Psychiatry Date: 2016-01-21 Impact factor: 9.319